TSO500 Sequencing on NovaSeq 6000 - MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 - Germany

MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht - Downloaded Version 2027.0.0-ballot.1 See the Directory of published versions

Example Procedure: TSO500 Sequencing on NovaSeq 6000

English

Profiles: MII PR MolGen Genomic Study Analysis, https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/genomic-study-analysis|2027.0.0-ballot.1

Genomic Study Analysis Specimen: Specimen: identifier = https://www.charite.de/fhir/sid/bioproben#specimen_tso500_ffpe_01; status = available; type = Formalin-fixed paraffin-embedded tissue specimen; receivedTime = 2024-05-16 09:20:00+0200

Genomic Study Analysis Device
device: Device: identifier = https://www.medizininformatik-initiative.de/fhir/sid/lab-devices#NOVASEQ-6000-SN12345; status = active; manufacturer = Illumina Inc.; serialNumber = SN12345; modelNumber = NovaSeq 6000; type = Medical laboratory analyzer

Genomic Study Analysis Method Type: Sequencing

Genomic Study Analysis Metrics
read-depth: 1000 reads (Details: UCUM code1 = '1')
sequencing-coverage: 95 percent (Details: UCUM code% = '%')
metrics-description: Mean target coverage 1000X; 95% der Zielregionen >250X; Q30 >90%; FFPE-bedingte Qualitätsfilter angewandt

status: Completed

category: Laboratory

subject: Maja Julia Van-der-Dussen (official) Female, DoB: 1968-09-19 ( Medical record number (use: usual, ))

IG © 2021+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.molgen#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-13
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.